TY - JOUR
T1 - Correction
T2 - A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory (Oncotarget (2017) 8 (41806-41814) DOI: 10.18632/oncotarget.16018
AU - Arango, Natalia Paez
AU - Brusco, Lauren
AU - Shaw, Kenna R.Mills
AU - Chen, Ken
AU - Eterovic, Agda Karina
AU - Holla, Vijaykumar
AU - Johnson, Amber
AU - Litzenburger, Beate
AU - Khotskaya, Yekaterina B.
AU - Sanchez, Nora
AU - Bailey, Ann
AU - Zheng, Xiaofeng
AU - Horombe, Chacha
AU - Kopetz, Scott
AU - Farhangfar, Carol J.
AU - Routbort, Mark
AU - Broaddus, Russell
AU - Bernstam, Elmer V.
AU - Mendelsohn, John
AU - Mills, Gordon B.
AU - Meric-Bernstam, Funda
N1 - Funding Information:
This work was supported in part by NCI 5T32CA009599, CPRIT RP 150535, the Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy, NCI U01 CA180964, NCATS grant UL1 TR000371 (Center for Clinical and Translational Sciences), the Nellie B. Connally Breast Cancer Research Endowment, and the MD Anderson Cancer Center Support Grant (CCSG) (P30 CA016672) and the CCSG supported Sequencing and Microarray Facility (SMF).
Publisher Copyright:
© 2019 Impact Journals LLC. All rights reserved.
PY - 2019
Y1 - 2019
N2 - This article has been corrected: The Acknowledgements information has been updated. The proper Acknowledgements section is shown below:.
AB - This article has been corrected: The Acknowledgements information has been updated. The proper Acknowledgements section is shown below:.
UR - http://www.scopus.com/inward/record.url?scp=85071727263&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071727263&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.27176
DO - 10.18632/oncotarget.27176
M3 - Comment/debate
C2 - 31497255
AN - SCOPUS:85071727263
SN - 1949-2553
VL - 10
SP - 5254
JO - Oncotarget
JF - Oncotarget
IS - 50
ER -